PhotoMedex's XTRAC(R) Excimer Laser Secures Additional Air Time on The LIFETIME Television's ''The Balancing Act'' May 16, 2008
Prior to opening the Weiss Skin Institute, he was Senior Medical Director at a biotechnology company in Palo Alto, California, and a resident in Dermatology at the Stanford University School of Medicine. A board-certified dermatologist, Dr. Weiss is a Fellow of the American Academy of Dermatology and a Diplomate of both the American Board of Dermatology and the National Board of Medical Examiners. (Yahoo! Wire -- Entertainment News)
Mouse cloned to cure Parkinson's May 16, 2008
The embryonic "stem cells", reports the journal Nature Biotechnology, were grown into new tissue which was implanted into the mouse brain. However, many obstacles stand in the way of human treatments, say experts. (Yahoo News -- Parkinson's Disease)
Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 May 15, 2008
About Progen: Progen Pharmaceuticals is a globally focused biotechnology company committed to the discovery, development and commercialization of small molecule pharmaceuticals primarily for the treatment of cancer. Progen has operations in Australia and the US. About PG-11047: PG-11047 is a polyamine analogue which modifies the production of natural polyamines. (PR Newswire)
Health Canada approves "Personalized medicine" for metastatic colorectal cancer May 15, 2008
A biotechnology medicine, Vectibix(TM) is the first fully human EGFr monoclonal antibody for the treatment of colorectal cancer ... With Canadian headquarters located in Mississauga's vibrant biomedical cluster, and a research facility in Burnaby, British Columbia, Amgen's Canadian affiliate has been an important contributor to Canada's biotechnology sector since 1991. (Canada Newswire)
News Stories May 15, 2008
Biotechnology and Genetics Full Coverage on Yahoo. News. (Yahoo News -- Biotechnology and Genetics)
Cancer drug sales could hit $80 billion by 2011: IMS May 15, 2008
IMS expects growth to be fueled by the introduction of 25 to 30 new chemical entities between 2008 and 2012, as expensive new biotechnology drugs and the increasing use of combination therapies contribute to the exploding cost of treatment. Data from clinical studies of many of the newest cancer drugs will be presented and discussed at the nation's largest oncology meeting later this month in Chicago. (Yahoo News -- Pharmaceutical Industry News)
Market wavers as drugs weigh; Citi down late May 15, 2008
Further dragging on the drug sector, biotechnology companies Genentech Inc (DNA.N) and Biogen Idec Inc (BIIB.O) said a study of one of its cancer treatments failed to show the drug was also effective for treating lupus. "Pharmaceuticals used to be the traditional recession play, but it seems they have so many negative stories, they can't get out of their own way," said Mark Schlarbaum, head trader at Global Capital Management in Conshohocken, Pennsylvania. (Yahoo News -- Pharmaceutical Industry News)
Model farmers (14) May 15, 2008
They told Hugh Grant, president and chief executive officer, and Terrel Crews, executive vice president and chief financial officer, to keep pushing biotechnology to make corn more insect and drought resistant. Strong roots, they said, are the key to big yields. (Waterloo-Cedar Falls Courier)
Teen Helps Design Classroom DNA Experiments Using Common Food Dyes May 15, 2008
One of the most frequently used tools in biochemistry and biotechnology, agarose gel electrophoresis is a common forensic technique often used in genetic or DNA fingerprinting. The procedure is achieved by moving negatively charged nucleic acid molecules through a gelatinous substance known as agarose by using an electric field. (Science Daily)
Premier issue of Environmental Justice just published May 15, 2008
Its biotechnology trade magazine, Genetic Engineering chnology News (GEN), was the first in its field and is today the industrys most widely read publication worldwide. A complete list of the firms 60 journals, books, and newsmagazines is available at. (EurekAlert! -- Business News)
What Cancer Doctors Know Kills ASCO Book for Traders Who Would Be Insiders May 15, 2008
May 14 (Bloomberg) -- , a biotechnology industry analyst, is working all night tomorrow to sort through an unprecedented torrent of almost 5,000 studies on new cancer treatments, looking for market-moving data ... The findings invariably leaked out, and the resulting insider trading caused shares of , and other biotechnology companies to fluctuate as much as 10 percent, the so-called ASCO effect ... Reviewing the data as it's published will be analysts such as Rodman & Renshaw Inc.'s King,... (Bloomberg)
Worker shortage predicted May 15, 2008
But he added, "You can do a lot to improve their nimbleness and ability to adjust to this fundamental change in the economy."North Carolina's economy is undergoing a radical reinvention, away from the old manufacturing empires of tobacco, textiles and furniture to pharmaceuticals, telecommunications, biotechnology, banking and financial services. The community college system has built-in impediments to responding, Coble said, including state funding that lags a year behind and anemic faculty... (News & Observer)
GM potato trials given go-ahead May 15, 2008
The biotechnology firm applied to the Department for Environment, Food and Rural Affairs (Defra) to hold trials at the headquarters of the National Institute of Agricultural Botany (NIAB) in Cambridge and on a farm at Draycott in Derbyshire. The GM potato crops are to be planted next spring, and trials will last several years. (Yahoo News -- Genetically Modified Food)
U.S. Uneasy About Biotech Food May 15, 2008
Few Americans favor the introduction of genetically modified foods, while many do not realize how widespread they already are, according to a Pew Initiative on Food and Biotechnology poll ... Michael Fernandez, executive director of the Pew Initiative on Food and Biotechnology, which sponsored the survey, said that overall, Americans are "still generally uncertain" about genetically modified and cloned foods. (Yahoo News -- Genetically Modified Food)
Genetically Engineered Rice Wins USDA Approval May 15, 2008
Joseph Mendelson, legal director of the nonprofit Center for Food Safety, said the quick approval shows that the USDA is more concerned about the fortunes of the biotechnology industry than about consumers' health. "USDA is telling agricultural biotechnology companies that it doesn't matter if you're negligent, if you break the rules, if you contaminate the food supply with untested genetically engineered crops, we'll bail you out," Mendelson said in a statement. (Yahoo News -- Genetically Modified Food)
Standard & Poor's Announces Changes to U.S. Indices May 14, 2008
Following is a summary of the changes: SAP 400 INDEX - May 15, 2008 COMPANY GICS ECONOMIC GICS SUB-INDUSTRY SECTOR ADDED Under Armour Consumer Apparel, Accessories Discretionary Luxury Goods DELETED IndyMac Bancorp Financials Thrifts age Finance SLCAP 600 INDEX - May 16, 2008 COMPANY GICS ECONOMIC GICS SUB-INDUSTRY SECTOR ADDED National Financials Insurance Brokers Financial Partners DELETED LifeCell Health Care Biotechnology Additions to and deletions from an Sty index do not in any way reflect... (PR Newswire)
Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin May 14, 2008
About Oncolytics Biotech Inc. Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. (PR Newswire)
Patheon Announces Executive Management Appointments May 14, 2008
Patheon operates a network of 10 manufacturing and six development facilities in the United States, Canada and Europe, employing more than 4,700 people and serving a customer base of 270 pharmaceutical and biotechnology companies. Caution Concerning Forward-Looking Statements This news release may contain forward-looking statements which reflect management's expectations regarding the Company's future growth of operations, performance (both operational and financial) and business prospects and... (Canada Newswire)
Haemacure financing receives shareholder consent - Series B Warrants are amended May 14, 2008
Haemacure has discovered eleven additional specialty proteins and enzymes in one of its two plasma fractions and seeks to advance these proteins and enzymes through partnerships with pharmaceutical and biotechnology companies. Haemacure operates offices in Sarasota, Florida through a wholly-owned subsidiary. (Canada Newswire)
High school gets biotechnology grant May 14, 2008
The Dover-Sherborn Regional School Committee approved the acceptance of a biotechnology grant to be used in the High School for the development of the biology department. The Regional High School will receive up to $11,000 in biotech lab supplies and $13,000 in lab consumables from the Massachusetts Biotechnology Education Foundation. (Dover Sherborn Tab, MA)
For Clinton, New Wealth In Speeches May 14, 2008
His paid speeches included $150,000 appearances before landlord groups, biotechnology firms and food distributors, as well as speeches in England, Ireland, New Zealand and Australia that together netted him more than $1. 6 million. (Yahoo News -- Bill Clinton)
Subsc00001174ribe May 14, 2008
Nature Biotechnology. Nature Cell Biology. (Nature News Service)
India suffers epidemic of stunted kids May 14, 2008
"We need to do more as a country because of the long-term consequences of undernourishment and we are not doing enough now," M.K. Bhan, secretary of the department of biotechnology in India said. In India, distribution of subsidized food for poor people through the government has miserably failed, officials say, with nearly one-third or even half of the food meant for poorest of the poor siphoned off by corrupt officials. (Globe and Mail)
Research advice from a Nobel Laureate May 14, 2008
He s on the top of the field in biotechnology and medicine. The 2007 Nobel Prize in Physiology or Medicine went to Capecchi along with Sir Martin J. Evans of Cardiff University (United Kingdom) and Oliver Smithies of the University of North Carolina at Chapel Hill for work on gene targeting. (Logan Herald Journal, UT)
Cytomedix Joins the Acute Long Term Hospital Association (ALTHA) as An Allied Member May 14, 2008
Cytomedix, Inc. is a biotechnology company specializing in processes and products derived from autologous platelet releasates for use on wounds and other applications. The current offering is the AutoloGel(tm) System, a process that utilizes an autologous platelet gel composed of multiple growth factors, other platelet releasates, and fibrin matrix. (Primezone Releases)
Have data, will partner May 14, 2008
For those that focus on research data pertaining to health, part of the answer lies with selling their expertise and access to their data to biotechnology, pharmaceutical and other for-profit businesses ... Local biotechnology and pharmaceutical companies, as well as contract research organizations, are outsourcing to Nielsen's independent, population-based research organization headquartered in Fremont for its expertise in the epidemiological studies of cancer. (San Jose Business Journal, CA)
DNA fingerprinting simplified May 14, 2008
KNOXVILLE, TN Agarose gel electrophoresis" Most teenagers wouldnt have a clue what this scientific term means, but middle school student Andrew Trigiano knows the protocol inside and out. When Andrew was 12, his father Robert Trigiano, a professor at the University of Tennessee, was looking for an interesting science project for his son. Setting out to compare differences in popular brands of Easter egg dyes, Trigianos project soon grew into a full-blown scientific study and set of... (EurekAlert!)
Rensselaer student invents alternative to silicon chip May 14, 2008
Rensselaer faculty are known for pre-eminence in research conducted in a wide range of fields, with particular emphasis in biotechnology, nanotechnology, information technology, and the media arts and technology. The Institute is well known for its success in the transfer of technology from the laboratory to the marketplace so that new discoveries and inventions benefit human life, protect the environment, and strengthen economic development. (EurekAlert!)
Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation May 13, 2008
About Intercell AG: Intercell AG is a growing biotechnology company which focuses on the design and development of novel vaccines for the prevention and treatment of infectious diseases with substantial unmet medical need. The Company develops antigens and adjuvants which are derived from its proprietary technology platforms and has in-house GMP manufacturing capabilities. (PR Newswire)
Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research May 13, 2008
Feldmann said, "We are very pleased with the widespread clinical applicability of our discovery that a messenger molecule, TNF, was an effective target for treatment not only in rheumatoid arthritis but also other chronic inflammatory conditions, such as inflammatory bowel disease, ankylosing spondylitis and psoriasis. This discovery suggested that other cytokine messenger molecules are also good treatment targets and has led to an emerging branch of medicine -- anti-cytokine therapy. I believe... (PR Newswire)
University Research and Science Parks Create Sustainable Innovation May 13, 2008
Experts in park development will gather in La Jolla on June 16 to share information on the best practices and emerging trends in maximizing the effectiveness of parks specializing in biotechnology development. BioParks 2008, a joint meeting of the Association of University Research Parks and Bio's Council of Biotechnology Centers, will feature intensive sessions centering on topics such as: -- enhancing translational research (the process of taking new discoveries from the laboratory to... (PR Newswire)
BioMs Medical to present at TIDES(R) Conference May 13, 2008
For more information visit: About BioMS Medical Corp. ------------------------- BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. (Canada Newswire)
Five-step check for nano safety May 13, 2008
The group of experts says that if the global research community can take advantage of the safety infrastructure already in place for biotechnology and computing, then nanotechnology has a rosy future. But Dr Maynard, from the Woodrow Wilson International Center for Scholars in Washington DC, and colleagues say that the way science is carried out means it is ill-equipped to address novel risks from emerging technologies. (Yahoo News -- Nanotechnology)
Warming Up For Magnetic Resonance Imaging May 13, 2008
This research was supported by the Department of Energy's Office of Science, Office of Basic Energy Sciences; by the Deutsche Forschungsgemeinschaft; and by the University of California's Biotechnology Research and Education Program. Journal reference. (Science Daily)
Neurocrine shares plunge on FDA rejection May 13, 2008
Shares in plummeted to their lowest level in more than five years, illustrating the peril faced by small companies -- including dozens of Boston area biotechnology firms -- whose value rests on a single product that has not yet reached the market. The FDA turned down an application by the 14-year-old San Diego company and , the world's largest drug maker, to sell a 15 milligram extended-release version of the insomnia drug Indiplon. (Yahoo News -- Sleep and Sleep Disorders)
Critical Outcome Technologies Inc. Announces Nomination for Early Stage Company of the Year May 13, 2008
This award is given to an emerging Canadian biotechnology company that has distinguished itself from its peers with demonstrated technology innovation and has achieved alliance and development milestones. ADVERTISEMENT. (CCNMatthews Press Releases)
Adherex Reports First Quarter 2008 Financial Results May 13, 2008
ADH-1 is a biotechnology compound which selectively targets N-cadherin, a protein present on certain tumor cells and the blood vessels of solid tumors. STS is a chemoprotectant being developed to reduce or prevent hearing loss that may result from treatment with platinum-based chemotherapy drugs. (CCNMatthews Press Releases)
New magazine prefers print May 13, 2008
Dispatches was funded by Simba Gill, former chief executive of biotechnology firm Maxygen. Rosenblum declined to say how much was contributed by Gill, who joined TPG Ventures, part of private equity firm Texas Pacific Group (TPG.UL), in 2006. (Globe and Mail -- Technology)
Hemispherx Biopharma, Inc. Releases Financial Results for the Three Months Ended March 31, 2008 May 13, 2008
Biotechnology Headlines. More Finance RSS Feeds. (Primezone Releases)
Biotech Aldagen plans an IPO May 13, 2008
President and chief operating officer: Edward L. Field, 43, is a Duke University alumnus who joined Aldagen in November 2004 after serving as CEO of biotechnology company Inologic ... Advertisements By Sabine Vollmer, Staff Writer A small Durham biotechnology company has filed plans to sell stock to the public, taking a leap of faith that Wall Street is recuperating. (News & Observer)
New to the Stable: Two Champion Clones May 13, 2008
View a Sample and Sign Up. World of Thoroughbred Racing Plans to Shun Breeding Venture. (Yahoo News -- Cloning)
Sunzen to list on Mesdaq May 13, 2008
We believe this will raise our profile as a reputable animal biotechnology corporation in our existing and future target markets. . (The Star Online, Malaysia -- Business)
Mouse cloned to cure Parkinson's May 13, 2008
The embryonic "stem cells", reports the journal Nature Biotechnology, were grown into new tissue which was implanted into the mouse brain. However, many obstacles stand in the way of human treatments, say experts. (Yahoo News -- Parkinson's Disease)
Taking credit May 12, 2008
The state's biotechnology industry, which lobbied hard for the right to sell a portion of their unused credits for much-needed cash, is pleased with how the credit swap program is working -- but it still sees opportunities for improvement. Companies who buy the credits use them to offset their state tax payments. (Philadelphia Business Journal, PA)
News Stories May 12, 2008
Biotechnology and Genetics Full Coverage on Yahoo. News. (Yahoo News -- Biotechnology and Genetics)
* Until the very last minute: Chen May 12, 2008
He visited a biotechnology park and attended the inauguration of a service center for an industrial and environmental park. He also made an appearance at his elementary school to inspect the completion of a new building. (Taipei Times, Taiwan -- World)
`Big Pharma' Drugmakers Increase Use of Asian Suppliers: Chart of the Day May 12, 2008
We see more companies beginning to look on contract manufacturing and research services players as partners rather than mere suppliers or vendors,'' Citigroup said in the May 8 report, based on the bank's annual survey of pharmaceutical and biotechnology companies ... With growing patent expiries, drying up of pipelines and need to focus on areas of core competence,'' outsourcing to Asian companies will become ``more of a strategic option for innovators rather than a mere tactical one adopted... (Bloomberg -- Asia)
Congress considers extending SBIR awards to VC-owned firms May 12, 2008
The Biotechnology Industry Organization and the National Venture Capital Association have been lobbying Congress to overturn this ruling ever since. They contend the high cost of bringing new drugs and other new technologies to the market force many companies to turn to venture capital firms for money. (Pacific Business News, HI)
Human Aging Gene Found In Flies May 12, 2008
ScienceDaily (May 12, 2008) Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have found a fast and effective way to investigate important aspects of human aging ... Dr Robert Saunders from The Open University added: "This work shows for the first time that we can use the short-lived fruit fly to investigate the function of an important human aging gene. We have opened up the exciting possibility of using this model system to analyse the way that such genes... (Science Daily)
Wanted: Skilled Workers May 12, 2008
The shortage of workers is such a concern in Oklahoma that legislators have drawn up a bill that would provide tax credits to attract and retain skilled workers in target industries, such as aerospace, energy, advanced manufacturing and processing, biotechnology, information technology and health care. Two other bills are designed to retain and attract engineers who move there. (Wichita Business Journal, KS)
For Clinton, New Wealth In Speeches May 12, 2008
His paid speeches included $150,000 appearances before landlord groups, biotechnology firms and food distributors, as well as speeches in England, Ireland, New Zealand and Australia that together netted him more than $1. 6 million. (Yahoo News -- Bill Clinton)
Bio baby steps May 12, 2008
A list of these companies kept by the 's Sid Martin Biotechnology Incubator has been growing longer each month, with South Florida leading the way with 45 bioscience companies. Since South Florida has only begun its biotech push, it has few companies that have successfully launched a product. (South Florida Business Journal, FL)
Nature's cleanup crew May 12, 2008
"Without the biotechnology and pharmaceutical industry there would be no new medications, and new medications are critically needed for people with mental disorders.". Doctors, mind your manners Politeness can never replace compassion, but a Beth Israel Deaconess doctor makes the case for what he calls "etiquette-based medicine" in this week's New England Journal of Medicine. (Boston Globe)
What the passage of GINA means for the public May 12, 2008
Bob Coughlin, president and CEO of the Massachusetts Biotechnology Council. "My wife and I are both carriers of the cystic fibrosis mutation, and we have a beautiful 6-year-old son who has cystic fibrosis, along with two older children who do not have it. We underwent genetic testing so we could be part of the process to cure this disease, and I would hate to think it could keep my wife or me from getting insurance or a job in the future.Genetic testing is a very touchy subject, and it's... (Boston Globe)
Osiris Therapeutics selling unit to NuVasive in deal worth up to $85M May 12, 2008
NuVasive CEO Alex Lukianov said in a statement the acquisition would give the company entr;e into a biotechnology market it estimates is worth $1. 5 billion. (Baltimore Business Journal, MD)
Genetically Engineered Rice Wins USDA Approval May 12, 2008
Joseph Mendelson, legal director of the nonprofit Center for Food Safety, said the quick approval shows that the USDA is more concerned about the fortunes of the biotechnology industry than about consumers' health. "USDA is telling agricultural biotechnology companies that it doesn't matter if you're negligent, if you break the rules, if you contaminate the food supply with untested genetically engineered crops, we'll bail you out," Mendelson said in a statement. (Yahoo News -- Genetically Modified Food)
GM potato trials given go-ahead May 12, 2008
The biotechnology firm applied to the Department for Environment, Food and Rural Affairs (Defra) to hold trials at the headquarters of the National Institute of Agricultural Botany (NIAB) in Cambridge and on a farm at Draycott in Derbyshire. The GM potato crops are to be planted next spring, and trials will last several years. (Yahoo News -- Genetically Modified Food)
U.S. Uneasy About Biotech Food May 12, 2008
Few Americans favor the introduction of genetically modified foods, while many do not realize how widespread they already are, according to a Pew Initiative on Food and Biotechnology poll ... Michael Fernandez, executive director of the Pew Initiative on Food and Biotechnology, which sponsored the survey, said that overall, Americans are "still generally uncertain" about genetically modified and cloned foods. (Yahoo News -- Genetically Modified Food)
Sunzen Biotech gets SC nod to list May 12, 2008
KUALA LUMPUR: Animal biotechnology specialist Sunzen Biotech Bhd has received the Securities Commissions (SC) approval to list on the Mesdaq market ... We believe this will raise our profile as a reputable animal biotechnology corporation in our existing and future target markets, he said ... The company, established in 1998, is involved in animal biotechnology research and development for health products used for animals. (The Star Online, Malaysia -- Business)
Biotech: Dental anesthesia reversal drug OK'd May 11, 2008
Weber has founded numerous San Diego biotechnology companies, including several that have been acquired by major pharmaceutical companies. His dentist, Dr. Howard Katz, knew this and liked to talk with Weber about his projects and the doctor's own ideas. (San Diego Union-Tribune)
Caught in a global food web May 11, 2008
To take advantage of higher food prices, some countries may adopt the use of biotechnology, especially genetically modified seed for crops. It is also likely that future research in seeds will focus more on yield-enhancing varieties rather than cost-reducing innovations. (India Times)
Five-step check for nano safety May 11, 2008
The group of experts says that if the global research community can take advantage of the safety infrastructure already in place for biotechnology and computing, then nanotechnology has a rosy future. But Dr Maynard, from the Woodrow Wilson International Center for Scholars in Washington DC, and colleagues say that the way science is carried out means it is ill-equipped to address novel risks from emerging technologies. (Yahoo News -- Nanotechnology)
Market wavers as drugs weigh; Citi down late May 11, 2008
Further dragging on the drug sector, biotechnology companies Genentech Inc (DNA.N) and Biogen Idec Inc (BIIB.O) said a study of one of its cancer treatments failed to show the drug was also effective for treating lupus. "Pharmaceuticals used to be the traditional recession play, but it seems they have so many negative stories, they can't get out of their own way," said Mark Schlarbaum, head trader at Global Capital Management in Conshohocken, Pennsylvania. (Yahoo News -- Pharmaceutical Industry News)
The next big thing May 11, 2008
Problem is, most of us are mystified and intimidated by such things as biotechnology, or nanotechnology, or the various other -ologies that seem to be threatening to merge into a single unspeakable and incomprehensible thing called biotechnonanogenomicology. We vaguely understand that this stuff is changing our lives, but we feel as though it's all out of our control. (Fresno Bee -- Opinion)
Lomax urges Claflin grads to build on King's legacy May 11, 2008
The James E. Hunter Faculty Excellence Award for the year was awarded to Dr. Omar Bagasra, a biology professor who is director of the South Carolina Center for Biotechnology at Claflin. The award, which carries a $1,000 stipend, recognized Bagasra s work that has resulted in more than $1 million in research funds being awarded to the university. (Orangeburg Times and Democrat, SC)
